20-20 Gene Systems launches L-IHC staining for biomarker identification in tumors 20/20 GeneSystems Click here.
20-20 Gene Systems launches L-IHC staining for biomarker identification in tumors 20/20 GeneSystems, Inc Click here . announced today at ADAPT 2010, a business meeting focusing on advancing personalized medication, the commercial start of their patented technology for biomarker identification in tumors and other tissue samples. 20/20 is currently offering the technology to sector and academic researchers under service contracts. L-IHC permits the simultaneous detection of multiple biomarkers in a single tissue section while preserving its morphology and removing several limitations linked to the few current multiplex histology techniques. It is especially useful for studies where multi-parametric information is essential and tissue supply is limiting, an average issue in translational and clinical analysis.